IRIS UniCatt

De Marinis Grasso, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.390
NA - Nord America 5.262
AS - Asia 4.114
SA - Sud America 1.070
AF - Africa 111
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.961
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.088
DE - Germania 2.166
SG - Singapore 1.869
CN - Cina 1.181
BR - Brasile 879
SE - Svezia 821
UA - Ucraina 557
IT - Italia 468
FR - Francia 317
VN - Vietnam 265
GB - Regno Unito 264
IE - Irlanda 222
IN - India 189
FI - Finlandia 173
ID - Indonesia 152
RU - Federazione Russa 126
CA - Canada 94
AR - Argentina 69
HK - Hong Kong 63
TR - Turchia 63
BD - Bangladesh 54
JP - Giappone 50
BE - Belgio 46
MX - Messico 46
IQ - Iraq 45
PL - Polonia 44
NL - Olanda 38
AT - Austria 34
EC - Ecuador 33
ES - Italia 29
ZA - Sudafrica 26
PK - Pakistan 23
CL - Cile 19
MA - Marocco 18
UZ - Uzbekistan 18
VE - Venezuela 17
KR - Corea 16
CO - Colombia 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
PY - Paraguay 13
CH - Svizzera 12
EG - Egitto 12
IR - Iran 12
KZ - Kazakistan 11
RO - Romania 10
AZ - Azerbaigian 9
CI - Costa d'Avorio 9
CZ - Repubblica Ceca 9
LT - Lituania 9
JO - Giordania 8
KE - Kenya 8
PT - Portogallo 8
AL - Albania 7
ET - Etiopia 7
SN - Senegal 7
AU - Australia 6
CR - Costa Rica 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
LK - Sri Lanka 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
MD - Moldavia 5
NP - Nepal 5
DO - Repubblica Dominicana 4
HN - Honduras 4
MY - Malesia 4
NG - Nigeria 4
NO - Norvegia 4
PH - Filippine 4
QA - Qatar 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
LV - Lettonia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
Totale 15.941
Salva come PNG Salva come JPEG
Città #
Chandler 847
Singapore 822
Ashburn 468
Beijing 224
Jacksonville 220
San Mateo 214
Dublin 213
Ann Arbor 206
New York 177
Los Angeles 157
Nanjing 149
Jakarta 135
Wilmington 126
Hefei 124
Boston 109
Nürnberg 98
Rome 96
Ho Chi Minh City 95
Munich 94
Houston 90
Marseille 89
Moscow 87
São Paulo 86
Dearborn 79
Milan 74
Woodbridge 69
Hanoi 65
Princeton 65
Chicago 64
Dallas 64
Hong Kong 59
Cattolica 52
Lawrence 52
Seattle 52
Redwood City 51
Frankfurt am Main 50
Nanchang 50
Helsinki 49
Kent 49
Bremen 48
The Dalles 46
Brussels 44
Mountain View 43
Zhengzhou 43
University Park 40
Montreal 38
Boardman 36
Hangzhou 35
Izmir 35
Santa Clara 35
Detroit 34
Buffalo 33
Delhi 33
Rio de Janeiro 32
Fairfield 31
Denver 28
Norwalk 28
Shanghai 28
Shenyang 28
Brooklyn 27
Lancaster 27
Turku 27
Fremont 26
Tokyo 26
Warsaw 26
London 24
Changsha 22
Leawood 22
Belo Horizonte 21
Kunming 21
Nuremberg 21
Tianjin 21
Guangzhou 20
Hebei 20
Orem 20
Düsseldorf 19
Redmond 19
Jiaxing 18
Lauterbourg 17
Poplar 17
Stockholm 17
Cambridge 16
Atlanta 15
Bexley 15
Seoul 15
Tashkent 15
Baghdad 14
Dhaka 14
Mumbai 14
Porto Alegre 14
Toronto 14
Vienna 14
Augusta 13
Chennai 13
Johannesburg 13
North Bergen 13
Hyderabad 12
Philadelphia 12
Portsmouth 12
Quito 12
Totale 7.326
Salva come PNG Salva come JPEG
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 276
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 256
Growth hormone in inflammatory bowel disease 242
Evaluation of antioxidants systems in pituitary-adrenal axis diseases. 228
Double pituitary adenomas 224
Seminal antioxidant capacity in pre- and postoperative varicocele 211
Predictors of morbidity and mortality in acromegaly, an Italian survey. 211
Evaluation of Antioxidant systems (Coenzyme Q10 and total antioxidant capacity) in morbidy obesity before and after biliopancreatic diversion 196
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 189
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 186
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 186
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 177
Male fertility and reduction in semen parameters: A single tertiary-care center experience 176
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 174
Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. 174
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 171
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 168
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 163
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 161
Primary hyperparathyroidism. Our experience 159
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 159
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 157
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 154
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 153
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 151
[Immunogenetic and functional study of first-degree relatives of patients with type I diabetes mellitus for identifying prediabetic subjects] 150
Isolated growth hormone deficiency: clinical entity? 146
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 144
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 144
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 144
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 142
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 141
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 140
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 138
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 137
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 135
[Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case] 134
Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition 133
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 133
Hypothalamitis: a diagnostic and therapeutic challenge 131
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade 130
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 130
Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity 130
Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men 129
Effects of Testosterone on antioxidant systems in male secondary hypogonadism. 127
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 127
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 127
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 122
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 122
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 120
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 120
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 118
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 116
Fertility and hypopituitarism 116
ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy 114
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 114
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 114
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 113
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 113
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 113
Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle 110
Prevalence of vertebral fractures in men with acromegaly 110
Endocrine evaluation of patients with benign lumps of the breast 109
GH receptor isoforms and skeletal fragility in acromegaly 109
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 108
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 107
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 107
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 107
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 106
Plasma prolactin response to gonadotropin-releasing hormone during benzodiazepine treatment 105
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 102
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 102
Empty sella syndrome: Multiple endocrine disorders. 102
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 100
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 99
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 98
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 98
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 97
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 97
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: A multicenter study 96
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 94
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 94
Vertebral fractures in patients with acromegaly: a 3-year prospective study 93
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 92
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 91
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 89
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 89
Vertebral fractures in males with prolactinoma. 87
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 87
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 87
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 86
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 86
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 85
Understanding the effect of acromegaly on the human skeleton. 85
Endocrine evaluation of patients with benign lumps of the breast 83
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 83
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 82
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 81
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 81
ACROSTUDY: the Italian experience 81
Totale 13.014
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021582 0 0 0 0 0 57 119 22 109 106 157 12
2021/20221.163 60 96 20 79 112 45 26 175 50 66 183 251
2022/20232.397 302 346 194 337 172 283 135 183 266 42 77 60
2023/20241.052 61 319 21 43 51 163 37 19 28 34 118 158
2024/20252.512 63 63 170 81 173 85 28 118 412 221 498 600
2025/20264.165 1.046 268 516 943 1.166 226 0 0 0 0 0 0
Totale 16.179